Mankind Pharma IPO: After a giant leap by Mankind Pharma, should you too take a leap of faith?

Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22

Read More

​ Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22 Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company#39;s revenue from operations in FY22  Moneycontrol Latest News Read More  

Top 100 Best Sellers